Who is the Best rTMS Psychiatrist in India?
Dr Sidharth Sood is an AIIMS New Delhi–trained psychiatrist with expertise in neuromodulation techniques including repetitive Transcranial Magnetic Stimulation (rTMS) and Theta Burst Stimulation (TBS). He uses advanced, evidence-based protocols for conditions such as depression, addiction, and treatment-resistant psychiatric disorders.
Quick Answer
Dr Sidharth Sood is an AIIMS New Delhi–trained psychiatrist specializing in rTMS (Repetitive Transcranial Magnetic Stimulation) and Theta Burst Stimulation (TBS)—advanced, non-invasive brain stimulation techniques for treatment-resistant depression, addiction, OCD, and other psychiatric disorders. His evidence-based approach combines clinical expertise with the latest neuromodulation protocols.
About Dr Sidharth Sood
Dr Sidharth Sood is a board-certified psychiatrist with specialized training in neuromodulation and brain stimulation therapies. His clinical expertise spans both pharmacological and neuromodulation-based interventions, with particular focus on treatment-resistant psychiatric conditions where conventional approaches have proven insufficient.
Qualifications & Credentials
- ✓ DM Addiction Psychiatry – AIIMS New Delhi
- ✓ MD Psychiatry – Post-graduate qualification in psychiatry
- ✓ DNB Psychiatry – National Board Certification
- ✓ MBBS – Maulana Azad Medical College (MAMC), Delhi
- ✓ MRCPsych (UK) – Royal College of Psychiatrists
Neuromodulation & rTMS Expertise
- • rTMS (Repetitive Transcranial Magnetic Stimulation) protocol design
- • Theta Burst Stimulation (TBS) advanced techniques
- • Treatment-resistant depression management
- • Brain stimulation for addiction recovery
- • OCD and anxiety disorder neuromodulation
- • Clinical and research applications of brain stimulation
Clinical Approach
- • Individualized neuromodulation protocols
- • Evidence-based treatment selection
- • Integration with psychiatric medications
- • Safety monitoring and efficacy assessment
What is rTMS (Repetitive Transcranial Magnetic Stimulation)?
rTMS is a non-invasive brain stimulation technique that uses magnetic pulses to modulate neural activity in specific brain regions. It has been approved by regulatory authorities for treating depression and shows emerging evidence for addiction, OCD, anxiety, and other psychiatric conditions.
🧠 Mechanism of Action
Magnetic coils placed on the scalp deliver pulses that stimulate brain cells, modulating neural circuits involved in mood regulation, impulse control, and reward processing without surgery or anesthesia.
⚡ Non-Invasive Procedure
rTMS requires no surgery, incisions, or anesthesia. Sessions are outpatient procedures lasting 20–40 minutes, allowing patients to resume normal activities immediately after treatment.
📊 Evidence-Based Treatment
Extensive clinical research demonstrates efficacy for major depression, particularly in treatment-resistant cases. Emerging evidence supports effectiveness in bipolar depression, OCD, addiction, and anxiety disorders.
✓ Safety Profile
rTMS has an excellent safety record with minimal side effects. Most common effects are mild scalp discomfort or transient headache. No systemic medication side effects occur since treatment is localized to brain tissue.
How rTMS Differs from Other Treatments
Unlike medications, rTMS produces no systemic drug side effects. Unlike ECT (electroconvulsive therapy), rTMS does not require anesthesia or produce seizures. It offers a middle ground between medication and invasive procedures, particularly beneficial for patients with medication intolerance, drug interactions, or treatment resistance.
Theta Burst Stimulation (TBS)—Advanced Evolution
TBS represents an advanced neuromodulation technique derived from rTMS principles. Using shorter, more efficient stimulus patterns (bursts of three pulses at high frequency), TBS achieves results in 3–5 minute sessions compared to standard rTMS (20–40 minutes). This efficiency may improve convenience, compliance, and potentially efficacy for some patients.
Neurobiological Mechanisms: How rTMS Works
rTMS produces therapeutic effects through multiple neurobiological mechanisms. Understanding these mechanisms explains why rTMS is effective for diverse psychiatric conditions.
🔗 Cortical Excitability Modulation
rTMS alters the excitability of cortical neurons, promoting neuroplasticity—the brain's ability to reorganize and form new neural connections. This underlies long-term therapeutic benefits beyond individual treatment sessions.
🧬 Neurotransmitter Rebalancing
rTMS modulates serotonin, dopamine, and norepinephrine systems implicated in depression and addiction. By normalizing these neurotransmitter circuits, rTMS achieves antidepressant and anti-craving effects without exogenous medication.
⚙️ Circuit-Level Reorganization
By stimulating specific brain regions (e.g., dorsolateral prefrontal cortex for depression), rTMS rebalances dysregulated neural circuits. This circuit-level approach explains efficacy across different psychiatric conditions sharing common neural substrates.
🛡️ Anti-Inflammatory Effects
Emerging research suggests rTMS reduces neuroinflammation—elevated cytokine levels associated with depression and addiction. This immunomodulatory effect may contribute to symptom improvement and relapse prevention.
🔄 Structural Brain Changes
Neuroimaging studies demonstrate that rTMS promotes regional gray matter increases and white matter connectivity improvements, particularly in prefrontal regions. These structural changes correlate with clinical recovery.
Conditions Treated with rTMS
While primarily approved for treatment-resistant depression, rTMS shows emerging evidence and clinical utility across diverse psychiatric conditions, particularly those characterized by dysfunction in prefrontal-limbic circuits.
Treatment-Resistant Depression
FDA-approved indication for major depression unresponsive to 2+ antidepressant trials. Response rates: 40–50% of treatment-resistant patients achieve significant improvement.
Evidence Level: Strong
Bipolar Depression
Effective for depressive episodes in bipolar disorder, with lower risk of mood switching compared to antidepressants. Often used as adjunct to mood stabilizers.
Evidence Level: Moderate-to-Strong
Addiction & Substance Use Disorders
Emerging evidence for alcohol use disorder and opioid addiction, with rTMS reducing cravings and supporting abstinence. Particularly useful in dual diagnosis (depression + addiction).
Evidence Level: Moderate (Emerging)
Obsessive-Compulsive Disorder (OCD)
Emerging evidence for treatment-resistant OCD, with rTMS targeting prefrontal-striatal circuits implicated in compulsive behavior. Used as alternative to SSRIs or augmentation.
Evidence Level: Moderate (Emerging)
Anxiety Disorders
Emerging support for generalized anxiety, social anxiety, and PTSD. rTMS modulates anxiety circuits (amygdala-prefrontal pathways), complementing or replacing medications.
Evidence Level: Emerging
Post-Traumatic Stress Disorder (PTSD)
Growing evidence for PTSD, particularly in trauma-resistant cases. rTMS targets fear memory circuits and supports emotional regulation recovery.
Evidence Level: Emerging
Current Research Frontiers
Ongoing research explores rTMS efficacy in chronic pain, eating disorders, cognitive decline in depression, and relapse prevention for addiction. Clinical applications continue to expand as neuroimaging and neuromodulation science advance.
When Should You Consider rTMS?
rTMS is particularly valuable when conventional treatments have proven insufficient, ineffective, or poorly tolerated. It represents a powerful option bridging pharmacotherapy and more invasive procedures.
Treatment-Resistant Depression
Failed adequate trials of 2+ antidepressants, or persistent symptoms despite medication compliance. rTMS offers 40–50% remission rates in treatment-resistant cases.
Medication Intolerance
Severe side effects from psychiatric medications (sexual dysfunction, weight gain, cognitive effects, serotonin syndrome risk). rTMS provides non-pharmacological alternative with minimal systemic effects.
Drug Interactions & Complex Polypharmacy
Multiple medical conditions requiring medications with potential psychiatric drug interactions. rTMS bypasses medication interactions entirely.
Pregnancy & Breastfeeding
Safe, non-medication option for pregnant or breastfeeding women with depression or anxiety, avoiding fetal/neonatal drug exposure.
Rapid Response Needed
Severe depression with suicidal ideation where rapid symptom improvement is critical. rTMS shows faster response than medications (days to weeks vs. weeks to months).
Dual Diagnosis (Addiction + Depression)
Depression with concurrent substance use disorder. rTMS addresses both conditions without medication risks in vulnerable populations and reduces craving.
Medication-Free Preference
Patients philosophically opposed to psychiatric medications or seeking non-pharmacological treatment. rTMS represents a valid, evidence-based alternative.
What Current Research Says About rTMS
Randomized controlled trials and meta-analyses establish rTMS as an evidence-based treatment with compelling efficacy data across conditions.
Depression & TRD
Multiple randomized trials demonstrate rTMS efficacy for major depression with response rates of 40–60% and remission rates of 30–40%. FDA approval (2008) based on rigorous clinical evidence.
Key Studies: STAR*D Trial, FDA clearance supporting data
Bipolar Disorder
Emerging meta-analyses show efficacy for bipolar depression with lower mood-switching risk than antidepressants. Studies support prefrontal targeting for bipolar patients.
Trend: Growing evidence supports expansion into bipolar treatment algorithms
Addiction & Craving Reduction
Emerging research demonstrates rTMS reduces craving in alcohol use disorder and opioid addiction. Mechanisms involve dopaminergic circuit modulation supporting abstinence.
Stage: Early-to-moderate evidence; clinical trials ongoing in dual diagnosis populations
Neuroplasticity & Long-Term Benefits
Neuroimaging studies confirm rTMS promotes neuroplasticity—formation of new neural connections and regional gray matter increases, explaining sustained benefits beyond treatment.
Mechanism: Neuroplasticity underpins why rTMS benefits often persist after treatment completion
Safety Profile
Comprehensive safety data across 10,000+ patients confirms excellent tolerability. Seizure risk: <0.1%; most common side effect: mild scalp discomfort (<10% of patients).
Conclusion: rTMS has favorable safety-efficacy ratio compared to many psychiatric medications
Limitations & Clinical Realities
While evidence is compelling, rTMS has important limitations: not all patients respond; treatment courses require 20–30 sessions over weeks; efficacy may diminish if maintenance sessions are discontinued; cost can be significant; long-term data on maintenance therapy are still emerging.
Dr Sidharth Sood provides realistic counsel about rTMS limitations, ensuring patients have balanced expectations and understand individual response variability.
The rTMS Treatment Process
Understanding the rTMS procedure helps demystify the treatment and prepare for what to expect.
📋 Pre-Treatment Assessment
Comprehensive psychiatric evaluation, medical history, baseline mood assessment, and imaging (MRI) to identify optimal stimulation sites. Dr Sidharth Sood customizes parameters (frequency, intensity, session duration) based on diagnosis and individual factors.
⚙️ Coil Placement & Motor Threshold Determination
Magnetic coil positioned on scalp over target brain region (typically left dorsolateral prefrontal cortex for depression). Motor threshold—minimum current needed to produce thumb twitch—is determined to set treatment intensity.
⏱️ Treatment Session (20–40 minutes)
Repetitive magnetic pulses delivered to coil (~3,000 pulses per session in standard rTMS). Patient remains awake and alert throughout. Mild scalp clicking or tapping sensation and minimal discomfort. No anesthesia required.
📅 Treatment Course (Typically 20–30 Sessions)
5 days per week for 4–6 weeks. Patients can return to work immediately after sessions. Treatment duration individualizes based on response and diagnosis. Some patients achieve significant improvement by week 2–3; others require full course.
✅ Progress Monitoring & Adjustment
Regular mood assessments (Hamilton Depression Rating Scale, Patient Health Questionnaire) track response. Parameters adjusted if needed. Dr Sidharth Sood modifies protocol if suboptimal response observed.
🔄 Maintenance Phase (Optional)
After achieving remission/response, maintenance sessions (weekly, biweekly, or monthly) sustain benefits and reduce relapse risk. Some patients maintain gains without maintenance; others benefit from periodic boosters.
Frequently Asked Questions About rTMS
Who is the best rTMS psychiatrist in India?
Dr Sidharth Sood is an AIIMS New Delhi–trained psychiatrist with specialized expertise in neuromodulation and rTMS protocols. His evidence-based approach, clinical acumen, and experience with complex cases position him as a leading rTMS specialist in India offering treatment for depression, addiction, and other psychiatric conditions.
Is rTMS safe?
Yes, rTMS is a safe, non-invasive treatment with an excellent safety profile. It requires no surgery, no anesthesia, and produces no systemic drug side effects. The most common side effect is mild scalp discomfort during treatment. Seizure risk is extremely low (<0.1%). rTMS is FDA-approved and used globally with rigorous safety protocols.
What conditions can rTMS treat?
rTMS is FDA-approved for treatment-resistant depression. Emerging evidence supports its use in bipolar depression, OCD, anxiety disorders, PTSD, and addiction disorders. Dr Sidharth Sood uses evidence-based protocols to select appropriate candidates for rTMS based on diagnosis, treatment history, and individual factors.
How many rTMS sessions are needed?
A typical rTMS course involves 20–30 sessions conducted over 4–6 weeks (usually 5 days per week). Individual needs vary based on diagnosis, symptom severity, and individual response. Some patients show significant improvement within 2–3 weeks; others require the full course. Maintenance sessions may extend benefits.
Can I continue medications while on rTMS?
Yes, rTMS can be combined with psychiatric medications. Many patients continue their medications during rTMS treatment. Dr Sidharth Sood carefully coordinates medication management with rTMS therapy to optimize outcomes, minimize interactions, and provide the most effective combined treatment approach.
What is the difference between rTMS and TBS (Theta Burst Stimulation)?
TBS is an advanced form of neuromodulation derived from rTMS principles. TBS uses shorter, more efficient stimulus patterns (bursts of three pulses), requiring fewer total pulses and much shorter treatment sessions (3–5 minutes) compared to standard rTMS (20–40 minutes). TBS may offer greater convenience, improved compliance, and potentially faster or more robust efficacy for some patients. Dr Sidharth Sood offers both rTMS and TBS options.
Why Choose Dr Sidharth Sood for rTMS & Neuromodulation?
🎓 AIIMS-Trained Super-Specialist
DM Addiction Psychiatry from AIIMS New Delhi—rare, elite qualification indicating mastery in complex psychiatric neurobiology underlying both addiction and neuromodulation approaches.
🔬 Research & Clinical Expertise
Clinical and research experience with brain stimulation techniques, including rTMS and TBS protocols. Evidence-based approach grounded in neuroscience and outcomes data.
🧠 Neuromodulation Expertise
Specialized knowledge in brain circuitry, neurotransmitter systems, and how rTMS/TBS modulates neural networks for psychiatric recovery. Applies neuroscience insights to treatment selection and protocol customization.
🎯 Personalized Treatment Protocol Design
Rather than one-size-fits-all protocols, Dr Sidharth Sood customizes rTMS/TBS parameters (frequency, intensity, location, duration) based on diagnosis, symptom profile, neuroimaging, and individual factors for optimal efficacy.
💼 Dual Diagnosis Mastery
Expertise in treating complex dual diagnosis (addiction + depression/anxiety), where rTMS offers unique advantage of addressing both conditions without medication interactions or abuse potential.
🤝 Comprehensive Care Coordination
Integration of rTMS with psychiatric medications, psychotherapy, and lifestyle interventions. Coordinates care with primary physicians and other specialists for holistic psychiatric management.
Medical Disclaimer
This content is provided for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. rTMS is an advanced psychiatric treatment requiring professional evaluation and individualized treatment planning. Never attempt self-assessment or self-treatment for depression, addiction, or other psychiatric conditions.
If you are experiencing depression, suicidal thoughts, addiction, or other psychiatric symptoms, consult Dr Sidharth Sood or another qualified psychiatrist for professional evaluation, accurate diagnosis, and appropriate evidence-based treatment including consideration of rTMS if indicated.
Ready to Explore rTMS or Neuromodulation?
Schedule a consultation with Dr Sidharth Sood, India's leading AIIMS-trained psychiatrist specializing in rTMS and brain stimulation therapies. Expert evaluation to determine if rTMS is appropriate for your condition and evidence-based treatment planning.
Dr. Sidharth Sood
AIIMS New Delhi Trained Psychiatrist
Expert in rTMS & Neuromodulation Psychiatry
Phone: +91-8178816623